SECOND AMENDED AND RESTATED CREDIT AGREEMENT Dated as of August 25, 2020 among USANA HEALTH SCIENCES, INC., a Utah corporation, as the Borrower, CERTAIN SUBSIDIARIES OF THE BORROWER PARTY HERETO, as the Guarantors, BANK OF AMERICA, N.A., as...Credit Agreement • August 27th, 2020 • Usana Health Sciences Inc • Medicinal chemicals & botanical products • New York
This SECOND AMENDED AND RESTATED CREDIT AGREEMENT is entered into as of August 25, 2020, among USANA HEALTH SCIENCES, INC., a Utah corporation (the “Borrower”), the Guarantors (defined herein), Lenders (defined herein), BANK OF AMERICA, N.A., as Administrative Agent, Swingline Lender and L/C Issuer, and BOFA SECURITIES, INC., as Arranger (defined herein).
EXHIBIT 10.6 STOCK PLEDGE AGREEMENTStock Pledge Agreement • May 18th, 1999 • Usana Inc • Medicinal chemicals & botanical products • Utah
1. Maturity Date. The maturity date of the Note is changed to May 31, ------------- 1999. Bank's commitment to make advances to Borrower under its line of credit is also extended to May 31, 1999. 2. Other Terms. Except as specifically amended by this...Loan Modification Agreement • August 11th, 1998 • Usana Inc • Medicinal chemicals & botanical products
a) Total Amount Available: $5,000,000 ---------- ( ) Subject to the provisions of any accounts receivable and/or inventory borrowing plan required herein; it is expressly understood that collateral ineligible for borrowing purposes is determined...Business Loan Agreement • August 11th, 1998 • Usana Inc • Medicinal chemicals & botanical products • Washington
DUE: September 1, 2004 TERM NOTE USANA, Inc. $10,000,000.00 Dated: September 20, 1999 Seattle, WashingtonTerm Note • September 24th, 1999 • Usana Inc • Medicinal chemicals & botanical products • Utah
REVOLVING NOTE USANA, Inc. $15,000,000.00 Dated: September 20, 1999 Seattle, Washington USANA, Inc., a Utah corporation ("Borrower") unconditionally promises to pay to the order of Bank of America, N.A. ("Bank"), at its Commercial Banking office, on...Revolving Note • September 24th, 1999 • Usana Inc • Medicinal chemicals & botanical products • Washington
This Note is governed by and shall be construed in accordance with the laws of the State of Washington. This Note is also governed by the Credit Agreement dated September 20, 1999, between Bank and Borrower (the "Agreement"), and all terms, conditions, and definitions of the Agreement are incorporated herein. This is the "Revolving Note" referred to in the Agreement.
USANA, INC. EMPLOYMENT AGREEMENTEmployment Agreement • August 11th, 1998 • Usana Inc • Medicinal chemicals & botanical products • Utah
RecitalsRedemption Agreement • September 24th, 1999 • Usana Inc • Medicinal chemicals & botanical products • Utah
CREDIT AGREEMENTCredit Agreement • September 24th, 1999 • Usana Inc • Medicinal chemicals & botanical products • Washington
RecitalsCredit Agreement • August 23rd, 2002 • Usana Health Sciences Inc • Medicinal chemicals & botanical products • Washington
USANA HEALTH SCIENCES, INC. 2015 EQUITY INCENTIVE AWARD PLAN STOCK-SETTLED STOCK APPRECIATION RIGHT AWARD AGREEMENT FOR INDEPENDENT DIRECTORSStock-Settled Stock Appreciation Right Award Agreement • July 31st, 2015 • Usana Health Sciences Inc • Medicinal chemicals & botanical products
SECOND AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT AND AMENDMENT TO LOAN DOCUMENTSCredit Agreement • February 23rd, 2016 • Usana Health Sciences Inc • Medicinal chemicals & botanical products • Washington
This SECOND AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT AND AMENDMENT TO LOAN DOCUMENTS (“Amendment”) is entered into as of February 19, 2016, among USANA HEALTH SCIENCES, INC., a Utah corporation (together with its successors, “Borrower”), USANA ACQUISITION CORP., a Utah corporation (“USANA Acquisition”), USANA SENSÉ COMPANY, INC., a Utah corporation (“USANA Sensé”), USANA HEALTH SCIENCES NEW ZEALAND, INC., a Delaware corporation (“USANA New Zealand”), USANA CANADA HOLDING, INC., a Delaware corporation (“USANA Canada”), FMG PRODUCTIONS, INC., a Utah corporation (“FMG”), INTERNATIONAL HOLDINGS, INC., a Delaware corporation (“Holdings”), USANA HEALTH SCIENCES CHINA, INC., a Delaware corporation (“China”), PET LANE, INC., a Delaware corporation (“Pet Lane”), UHS ESSENTIAL HEALTH PHILIPPINES, INC., a Utah corporation (“UHS” and together with USANA Acquisition, USANA Sensé, USANA New Zealand, USANA Canada, FMG, Holdings, China, Pet Lane and their respective successors, collectively,
USANA HEALTH SCIENCES, INC. 2015 EQUITY INCENTIVE AWARD PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT FOR INDEPENDENT DIRECTORSRestricted Stock Unit Award Agreement • July 31st, 2015 • Usana Health Sciences Inc • Medicinal chemicals & botanical products
USANA HEALTH SCIENCES, INC. EMPLOYEE STOCK OPTION AGREEMENTEmployee Stock Option Agreement • April 26th, 2006 • Usana Health Sciences Inc • Medicinal chemicals & botanical products • Utah
This Stock Option Agreement (“Agreement”) is entered into as of the day of , between USANA HEALTH SCIENCES, INC., a Utah corporation (the “Company”), and (“Optionee”).
USANA HEALTH SCIENCES, INC. EMPLOYEE INCENTIVE STOCK OPTION AGREEMENTEmployee Incentive Stock Option Agreement • April 26th, 2006 • Usana Health Sciences Inc • Medicinal chemicals & botanical products • Utah
This Incentive Stock Option Agreement (“Agreement”) is entered into as of the day of , between USANA HEALTH SCIENCES, INC., a Utah corporation (the “Company”), and (“Optionee”).
Exhibit 10.1 USANA Health Sciences, Inc. DIRECTOR INDEMNIFICATION AGREEMENT This Indemnification Agreement ("Agreement") is made and entered into as of [_____________], between USANA Health Sciences, Inc., a Utah corporation (the "Company") and...Director Indemnification Agreement • May 24th, 2006 • Usana Health Sciences Inc • Medicinal chemicals & botanical products • Utah
USANA HEALTH SCIENCES, INC. 2006 EQUITY INCENTIVE AWARD PLAN STOCK-SETTLED STOCK APPRECIATION RIGHT AWARD AGREEMENT FOR INDEPENDENT DIRECTORSStock-Settled Stock Appreciation Right Award Agreement • April 26th, 2006 • Usana Health Sciences Inc • Medicinal chemicals & botanical products
FIRST AMENDMENT TO CREDIT AGREEMENTCredit Agreement • May 11th, 2021 • Usana Health Sciences Inc • Medicinal chemicals & botanical products • New York
THIS FIRST AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”), dated as of April 21, 2021, is by and among USANA HEALTH SCIENCES, INC., a Utah corporation (the “Borrower”), the Guarantors party hereto, the Lenders party hereto and BANK OF AMERICA, N.A., as administrative agent (in such capacity, the “Administrative Agent”).
AMENDED REVOLVING NOTERevolving Note • March 30th, 2001 • Usana Health Sciences Inc • Medicinal chemicals & botanical products • Washington
This Note is governed by and shall be construed in accordance with the laws of the State of Washington. This Note is also governed by the Credit Agreement dated March 26, 2001, between Bank and Borrower (the "Agreement"), and all terms, conditions, and definitions of the Agreement are incorporated herein. This Note amends, restates and continues that certain Revolving Note made by Borrower in favor of Bank dated September 20, 1999 in the amount of $15,000,000 (as amended from time to time, the "Prior Note"). The indebtedness evidenced by the Prior Note has not been repaid, satisfied or discharged and nothing herein shall constitute a repayment, satisfaction or discharge of such indebtedness. This is the "Revolving Note" referred to in the Agreement.
THIRD AMENDMENT TO CREDIT AGREEMENTCredit Agreement • March 27th, 2003 • Usana Health Sciences Inc • Medicinal chemicals & botanical products • Washington
THIS THIRD AMENDMENT TO CREDIT AGREEMENT (“Amendment”) is made and entered into by and between USANA Health Sciences, Inc., a Utah corporation (“Borrower”) and Bank of America, N.A., a national banking association (“Bank”).
AMENDED AND RESTATED CREDIT AGREEMENT Dated as of April 27, 2011 between USANA HEALTH SCIENCES, INC., as Borrower, BANK OF AMERICA, N.A., as BankCredit Agreement • April 28th, 2011 • Usana Health Sciences Inc • Medicinal chemicals & botanical products • Washington
This AMENDED AND RESTATED CREDIT AGREEMENT (“Agreement”) is entered into as of April 27, 2011, between USANA HEALTH SCIENCES, INC., a Utah corporation (“Borrower”) and BANK OF AMERICA, N.A., a national banking association (“Bank”).
USANA HEALTH SCIENCES, INC. 2015 EQUITY INCENTIVE AWARD PLAN STOCK-SETTLED STOCK APPRECIATION RIGHT AWARD AGREEMENT FOR EMPLOYEESStock-Settled Stock Appreciation Right Award Agreement • July 31st, 2015 • Usana Health Sciences Inc • Medicinal chemicals & botanical products
USANA HEALTH SCIENCES, INC. 2015 EQUITY INCENTIVE AWARD PLAN DEFERRED STOCK UNIT AGREEMENT FOR INDEPENDENT DIRECTORSDeferred Stock Unit Agreement • July 31st, 2015 • Usana Health Sciences Inc • Medicinal chemicals & botanical products • Utah
USANA HEALTH SCIENCES, INC. 2006 EQUITY INCENTIVE AWARD PLAN STOCK-SETTLED STOCK APPRECIATION RIGHT AWARD AGREEMENT FOR EMPLOYEESStock-Settled Stock Appreciation Right Award Agreement • April 26th, 2006 • Usana Health Sciences Inc • Medicinal chemicals & botanical products
CONSENT AND FOURTH AMENDMENT TO CREDIT AGREEMENTCredit Agreement • March 12th, 2004 • Usana Health Sciences Inc • Medicinal chemicals & botanical products • Washington
THIS CONSENT AND FOURTH AMENDMENT TO CREDIT AGREEMENT (“Amendment”) is made and entered into by and between USANA Health Sciences, Inc., a Utah corporation (“Borrower”) and Bank of America, N.A., a national banking association (“Bank”).
USANA HEALTH SCIENCES, INC. CONFIDENTIALITY, NON-DISCLOSURE AND NON- SOLICITATION AGREEMENTConfidentiality Agreement • November 9th, 2011 • Usana Health Sciences Inc • Medicinal chemicals & botanical products • Utah
In consideration of employment or continued employment by USANA Health Sciences, Inc. or any of its affiliates or subsidiaries (collectively, “USANA”), the compensation paid by USANA from time to time, and other good and valuable consideration, the undersigned employee of USANA hereby represents to and agrees with USANA as follows:
SHARE PURCHASE AGREEMENT among PET LANE, INC., USANA HEALTH SCIENCES, INC. and YAOLAN LTD. Dated: August 16, 2010Share Purchase Agreement • August 16th, 2010 • Usana Health Sciences Inc • Medicinal chemicals & botanical products • New York
· Pet Lane, Inc., a corporation incorporated under the laws of Delaware with its principal address at 2291 Via De Mercados, Suite E, Concord, CA 94520, U.S.A. (the “Buyer”);
AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENTCredit Agreement • July 23rd, 2013 • Usana Health Sciences Inc • Medicinal chemicals & botanical products • Washington
This AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT (“Amendment”) is entered into as of July 18, 2013, by USANA HEALTH SCIENCES, INC., a Utah corporation (together with its successors, “Borrower”), and BANK OF AMERICA, N.A., a national banking association (together with its successors and assigns, “Bank”).
THIRD AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENTCredit Agreement • July 19th, 2019 • Usana Health Sciences Inc • Medicinal chemicals & botanical products • Washington
This THIRD AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT (“Amendment”) is entered into as of July 15, 2019, by USANA HEALTH SCIENCES, INC., a Utah corporation (together with its successors, “Borrower”), and BANK OF AMERICA, N.A., a national banking association (together with its successors and assigns, “Bank”).
AMENDMENT TO CREDIT AGREEMENTCredit Agreement • May 7th, 2007 • Usana Health Sciences Inc • Medicinal chemicals & botanical products • Washington
This AMENDMENT TO CREDIT AGREEMENT (“Amendment”) is entered into as of April 24, 2007, by USANA HEALTH SCIENCES, INC., a Utah corporation (together with its successors, “Borrower”), and BANK OF AMERICA, N.A., a national banking association (together with its successors and assigns, “Bank”).
USANA HEALTH SCIENCES, INC. INDEPENDENT DIRECTOR STOCK OPTION AGREEMENTIndependent Director Stock Option Agreement • April 26th, 2006 • Usana Health Sciences Inc • Medicinal chemicals & botanical products • Utah
This Stock Option Agreement (“Agreement”) is entered into as of the day of , between USANA HEALTH SCIENCES, INC., a Utah corporation (the “Company”), and (“Optionee”).
AMENDED CREDIT AGREEMENT CREDIT AGREEMENTCredit Agreement • March 30th, 2001 • Usana Health Sciences Inc • Medicinal chemicals & botanical products • Washington
THIS CREDIT AGREEMENT ("Agreement") is made between USANA Health Sciences, Inc., a Utah corporation ("Borrower"), and Bank of America, N.A., a national banking association ("Bank").
ContractCredit Agreement • November 8th, 2022 • Usana Health Sciences Inc • Medicinal chemicals & botanical products • New York
AMENDED TERM NOTETerm Note • March 30th, 2001 • Usana Health Sciences Inc • Medicinal chemicals & botanical products • Washington
This Note is governed by and shall be construed in accordance with the laws of the State of Washington. This Note is also governed by the Credit Agreement dated March 26, 2001, between Bank and Borrower (the "Agreement"), and all terms, conditions, and definitions of the Agreement are incorporated herein. This Note amends, restates and continues that certain Revolving Note made by Borrower in favor of Bank dated September 20, 1999 in the amount of $10,000,000 (as amended from time to time, the "Prior Note"). The indebtedness evidenced by the Prior Note has not been repaid, satisfied or discharged and nothing herein shall constitute a repayment, satisfaction or discharge of such indebtedness. This is the "Term Note" referred to in the Agreement.
ContractNonqualified Deferred Compensation Plan Adoption Agreement • November 10th, 2021 • Usana Health Sciences Inc • Medicinal chemicals & botanical products
NOTE: Execution of this Adoption Agreement creates a legal liability of the Employer with significant tax consequences to the Employer and Participants. Principal Life Insurance Company disclaims all liability for the legal and tax consequences which result from the elections made by the Employer in this Adoption Agreement. Nothing set forth in this agreement or related documents may be taken or relied upon as legal, tax, investment, or accounting advice, nor as any investment recommendation. You should consult with appropriate counsel or other advisors on all matters pertaining to legal, tax, or accounting obligations and requirements.
